Ghezzi, A <br/><br/>
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmart™-the FUTURE study.  [electronic resource] 

 -  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology  Nov 2017 
 - 1999-2005 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1590-3478 
<br/><br/><label>Standard No.: </label>10.1007/s10072-017-3091-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Adolescent<br/>Child<br/>Drug Delivery Systems<br/>Fatigue<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon beta-1a--administration & dosage<br/>Male<br/>Medication Adherence<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Parents<br/>Prospective Studies<br/>Quality of Life<br/>Self Report<br/>Treatment Outcome